Biotech's Next Big Thing: Vertex
TheStreet senior columnist Adam Feuerstein explains why Vertex Pharmaceuticals is the next big thing in biotech.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
